https://www.selleckchem.com/pr....oducts/atezolizumab.
Intervention arm prescription of biotherapy (rituximab, adalimumab, abatacept) using SinnoTest® software, a prediction software based on proteomic biomarkers. Control arm prescription of biotherapy based on current practice, without the SinnoTest® software (any biotherapy). In addition, a substudy will be carried out within this trial to generate a biobank and further analyze the proteomic profile of the patients and their modification throughout the study. This clinical trial study will be the first validation study of a biotherap
Like
Comment
Share
